Stericycle
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. The last earnings update was 18 days ago. More info.
Add to Portfolio Compare Print
SRCL Share Price and Events
7 Day Returns
1 Year Returns
SRCL Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Stericycle (SRCL) | -1.2% | -13.7% | 6.9% | -24.3% | -49.7% | -57% |
| US Commercial Services | 0.1% | 0.7% | 4.9% | 12.2% | 53.4% | 73.8% |
| US Market | -0.7% | -2% | 2.4% | 3% | 39.2% | 42% |
1 Year Return vs Industry and Market
- SRCL underperformed the Commercial Services industry which returned 12.2% over the past year.
- SRCL underperformed the Market in United States of America which returned 3% over the past year.
SRCL Value
Is Stericycle undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Stericycle
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Stericycle.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 12 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.2% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Commercial Services Unlevered Beta | Simply Wall St/ S&P Global | 0.72 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.718 (1 + (1- 21%) (72.76%)) |
1.088 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.09 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.088 * 5.96%) |
9.21% |
Discounted Cash Flow Calculation for NasdaqGS:SRCL using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Stericycle is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.21%) |
|
|---|---|---|---|
| 2019 | 219.19 | Analyst x5 | 200.69 |
| 2020 | 330.45 | Analyst x4 | 277.04 |
| 2021 | 369.01 | Est @ 11.67% | 283.27 |
| 2022 | 402.18 | Est @ 8.99% | 282.68 |
| 2023 | 430.78 | Est @ 7.11% | 277.24 |
| 2024 | 455.75 | Est @ 5.8% | 268.56 |
| 2025 | 477.97 | Est @ 4.88% | 257.90 |
| 2026 | 498.20 | Est @ 4.23% | 246.13 |
| 2027 | 517.05 | Est @ 3.78% | 233.89 |
| 2028 | 534.97 | Est @ 3.47% | 221.58 |
| Present value of next 10 years cash flows | $2,549.00 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $534.97 × (1 + 2.73%) ÷ (9.21% – 2.73%) |
$8,475.40 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $8,475.40 ÷ (1 + 9.21%)10 |
$3,510.46 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $2,549.00 + $3,510.46 |
$6,059.46 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $6,059.46 / 91.04 |
$66.56 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $66.56 |
| Current discount | Discount to share price of
$48.34
= -1 x ($48.34 - $66.56) / $66.56 |
27.4% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Stericycle's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Stericycle's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Stericycle's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Stericycle's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2019-03-31) in USD | $-3.53 |
| NasdaqGS:SRCL Share Price ** | NasdaqGS (2019-05-17) in USD | $48.34 |
| United States of America Commercial Services Industry PE Ratio | Median Figure of 50 Publicly-Listed Commercial Services Companies | 22.86x |
| United States of America Market PE Ratio | Median Figure of 3,088 Publicly-Listed Companies | 17.89x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Stericycle.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NasdaqGS:SRCL Share Price ÷ EPS (both in USD) = 48.34 ÷ -3.53 |
-13.69x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Stericycle is loss making, we can't compare its value to the US Commercial Services industry average.
- Stericycle is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does
Stericycle's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | -13.69x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts |
94.2%per year |
| United States of America Commercial Services Industry PEG Ratio | Median Figure of 34 Publicly-Listed Commercial Services Companies | 1.79x |
| United States of America Market PEG Ratio | Median Figure of 2,117 Publicly-Listed Companies | 1.56x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Stericycle, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Stericycle's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2019-03-31) in USD | $28.27 |
| NasdaqGS:SRCL Share Price * | NasdaqGS (2019-05-17) in USD | $48.34 |
| United States of America Commercial Services Industry PB Ratio | Median Figure of 88 Publicly-Listed Commercial Services Companies | 1.9x |
| United States of America Market PB Ratio | Median Figure of 5,195 Publicly-Listed Companies | 1.83x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NasdaqGS:SRCL Share Price ÷ Book Value per Share (both in USD) = 48.34 ÷ 28.27 |
1.71x |
* Primary Listing of Stericycle.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Stericycle is good value based on assets compared to the US Commercial Services industry average.
Value checks
We assess Stericycle's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Commercial Services industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Commercial Services industry average (and greater than 0)? (1 check) Stericycle has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
SRCL Future Performance
How is Stericycle expected to perform in the next 1 to 3 years based on estimates from 12 analysts?
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Stericycle's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Stericycle's earnings growth is expected to exceed the United States of America market average.
- Stericycle's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NasdaqGS:SRCL Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts | 94.2% |
| NasdaqGS:SRCL Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 12 Analysts | 3.4% |
| United States of America Commercial Services Industry Earnings Growth Rate | Market Cap Weighted Average | 15.2% |
| United States of America Commercial Services Industry Revenue Growth Rate | Market Cap Weighted Average | 5.3% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.9% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.3% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 12 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 3,944 | 1 | ||
| 2022-12-31 | 3,816 | 1 | ||
| 2021-12-31 | 3,647 | 3 | ||
| 2020-12-31 | 3,485 | 481 | 221 | 12 |
| 2019-12-31 | 3,403 | 405 | 97 | 12 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2019-03-31 | 3,421 | 92 | -312 |
| 2018-12-31 | 3,486 | 166 | -253 |
| 2018-09-30 | 3,521 | 207 | 148 |
| 2018-06-30 | 3,549 | 501 | 166 |
| 2018-03-31 | 3,583 | 451 | -9 |
| 2017-12-31 | 3,581 | 509 | 23 |
| 2017-09-30 | 3,599 | 535 | -47 |
| 2017-06-30 | 3,607 | 554 | -21 |
| 2017-03-31 | 3,581 | 572 | 165 |
| 2016-12-31 | 3,562 | 561 | 178 |
| 2016-09-30 | 3,544 | 515 | 236 |
| 2016-06-30 | 3,373 | 457 | 244 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 12 Analyst Estimates (S&P Global) | See Below |
All data from Stericycle Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | ||||
| 2022-12-31 | ||||
| 2021-12-31 | 3.45 | 3.45 | 3.45 | 1.00 |
| 2020-12-31 | 2.32 | 2.96 | 1.68 | 7.00 |
| 2019-12-31 | 1.12 | 1.84 | 0.53 | 7.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2019-03-31 | -3.53 |
| 2018-12-31 | -2.91 |
| 2018-09-30 | 1.73 |
| 2018-06-30 | 1.95 |
| 2018-03-31 | -0.11 |
| 2017-12-31 | 0.27 |
| 2017-09-30 | -0.55 |
| 2017-06-30 | -0.25 |
| 2017-03-31 | 1.94 |
| 2016-12-31 | 2.10 |
| 2016-09-30 | 2.78 |
| 2016-06-30 | 2.88 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Stericycle's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Stericycle has a total score of 3/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
SRCL Past Performance
How has Stericycle performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Stericycle does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- Unable to compare Stericycle's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Unable to compare Stericycle's 1-year growth to the US Commercial Services industry average as it is not currently profitable.
Earnings and Revenue History
All data from Stericycle Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2019-03-31 | 3,421.00 | -312.10 | 792.00 | |
| 2018-12-31 | 3,485.90 | -253.30 | 804.90 | |
| 2018-09-30 | 3,521.00 | 148.40 | 1,041.80 | |
| 2018-06-30 | 3,548.90 | 166.40 | 1,000.60 | |
| 2018-03-31 | 3,583.30 | -9.00 | 877.70 | |
| 2017-12-31 | 3,580.70 | 23.40 | 840.20 | |
| 2017-09-30 | 3,599.25 | -47.21 | 986.95 | |
| 2017-06-30 | 3,606.60 | -21.17 | 1,025.41 | |
| 2017-03-31 | 3,580.52 | 164.92 | 965.33 | |
| 2016-12-31 | 3,562.30 | 178.20 | 777.10 | |
| 2016-09-30 | 3,544.25 | 236.23 | 715.11 | |
| 2016-06-30 | 3,372.70 | 244.14 | 660.87 | |
| 2016-03-31 | 3,196.77 | 294.68 | 604.69 | |
| 2015-12-31 | 2,985.90 | 256.90 | 594.30 | |
| 2015-09-30 | 2,774.55 | 268.75 | 506.29 | |
| 2015-06-30 | 2,723.83 | 282.14 | 495.10 | |
| 2015-03-31 | 2,648.97 | 276.25 | 481.99 | |
| 2014-12-31 | 2,555.60 | 326.46 | 433.87 | |
| 2014-09-30 | 2,446.55 | 322.09 | 427.91 | |
| 2014-06-30 | 2,313.26 | 319.80 | 407.54 | |
| 2014-03-31 | 2,198.96 | 315.90 | 384.03 | |
| 2013-12-31 | 2,142.81 | 311.37 | 380.31 | |
| 2013-09-30 | 2,078.55 | 303.28 | 358.86 | |
| 2013-06-30 | 2,024.45 | 288.21 | 352.94 | |
| 2013-03-31 | 1,966.88 | 277.76 | 342.43 | |
| 2012-12-31 | 1,913.15 | 268.00 | 348.92 | |
| 2012-09-30 | 1,856.07 | 262.22 | 321.85 | |
| 2012-06-30 | 1,796.51 | 255.99 | 307.71 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- It is difficult to establish if Stericycle has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- It is difficult to establish if Stericycle has efficiently used its assets last year compared to the US Commercial Services industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Stericycle improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Past performance checks
We assess Stericycle's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Commercial Services industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Stericycle has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
SRCL Health
How is Stericycle's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Stericycle's finances.
The net worth of a company is the difference between its assets and liabilities.
- Stericycle is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Stericycle's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is not covered by short term assets, assets are 0.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Stericycle Company Filings, last reported 1 month ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2019-03-31 | 2,570.50 | 3,202.00 | 48.20 |
| 2018-12-31 | 2,597.10 | 2,783.00 | 34.30 |
| 2018-09-30 | 2,932.60 | 2,838.00 | 52.00 |
| 2018-06-30 | 2,901.60 | 2,654.50 | 45.00 |
| 2018-03-31 | 2,952.10 | 2,720.70 | 49.40 |
| 2017-12-31 | 2,908.60 | 2,741.80 | 42.20 |
| 2017-09-30 | 2,818.72 | 2,778.50 | 52.17 |
| 2017-06-30 | 2,760.82 | 2,861.22 | 44.19 |
| 2017-03-31 | 2,892.48 | 2,863.34 | 47.02 |
| 2016-12-31 | 2,816.40 | 2,954.50 | 44.20 |
| 2016-09-30 | 2,858.79 | 3,012.78 | 40.35 |
| 2016-06-30 | 2,829.08 | 3,118.46 | 44.38 |
| 2016-03-31 | 2,818.49 | 3,152.15 | 45.72 |
| 2015-12-31 | 2,747.84 | 3,201.76 | 55.70 |
| 2015-09-30 | 2,734.44 | 1,516.09 | 669.17 |
| 2015-06-30 | 1,982.02 | 1,668.01 | 33.06 |
| 2015-03-31 | 1,950.01 | 1,575.39 | 38.40 |
| 2014-12-31 | 1,917.19 | 1,659.22 | 22.62 |
| 2014-09-30 | 1,880.19 | 1,677.41 | 42.46 |
| 2014-06-30 | 1,852.34 | 1,715.20 | 25.81 |
| 2014-03-31 | 1,785.55 | 1,370.38 | 43.41 |
| 2013-12-31 | 1,767.54 | 1,431.04 | 67.58 |
| 2013-09-30 | 1,722.73 | 1,403.17 | 64.03 |
| 2013-06-30 | 1,649.44 | 1,318.63 | 18.46 |
| 2013-03-31 | 1,625.47 | 1,272.70 | 13.20 |
| 2012-12-31 | 1,557.32 | 1,356.08 | 31.83 |
| 2012-09-30 | 1,492.86 | 1,297.15 | 16.67 |
| 2012-06-30 | 1,389.18 | 1,364.54 | 54.63 |
- Stericycle's level of debt (124.6%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (76.9% vs 124.6% today).
- Debt is not well covered by operating cash flow (2.9%, less than 20% of total debt).
- Stericycle is making a loss, therefore interest payments are not well covered by earnings.
Financial health checks
We assess Stericycle's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Stericycle has a total score of 1/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
SRCL Dividends
What is Stericycle's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Stericycle
shares you are expected to receive
$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Stericycle's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Stericycle's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 12 Analyst Estimates (S&P Global) | See Below |
| United States of America Commercial Services Industry Average Dividend Yield | Market Cap Weighted Average of 40 Stocks | 1.7% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2000 Stocks | 2.5% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | ||
| 2022-12-31 | ||
| 2021-12-31 | 0.00 | 1.00 |
| 2020-12-31 | 0.00 | 2.00 |
| 2019-12-31 | 0.00 | 2.00 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Stericycle has not reported any payouts.
- Unable to verify if Stericycle's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Stericycle's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Stericycle afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Stericycle has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
SRCL Management
CEO
| COMPENSATION | $2,375,730 |
| AGE | 55 |
| TENURE AS CEO | 0 years |
CEO Bio
Ms. Cindy J. Miller has been the President of Stericycle, Inc. since October 1, 2018, Chief Executive Officer since May 2, 2019 and as its Director since February 28, 2019. Ms. Miller served as Chief Operating Officer of Stericycle, Inc. from October 1, 2018 to May 2, 2019. Ms. Miller is responsible for the global operations of the Stericycle's medical waste, hazardous waste and secure information destruction lines, as well as the execution of Stericycle's Business Transformation. Ms. Miller joined Stericycle in October 2018 as part of an executive leadership development and succession planning process. Previously, Ms. Miller had a successful 30-year career at United Parcel Service (UPS) where she served in multiple roles of increasing leadership and international responsibility. She served as President of Global Freight Forwarding for United Parcel Service (UPS). She also served as President of UPS European Region and as Managing Director for several global and U.S. operating regions. Ms. Miller holds a B.A. in Humanities and Business from Pennsylvania State University and an Executive MBA from the London Business School.
CEO Compensation
- Insufficient data for Cindy to compare compensation growth.
- Cindy's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Stericycle management team in years:
- The average tenure for the Stericycle management team is less than 2 years, this suggests a new team.
Management Team
Cindy Miller
President
$2M
55
Dan Ginnetti
Executive VP & CFO
$2M
49
4.8 yrs
Kurt Rogers
Executive VP
$1M
46
1.8 yrs
Ruth-Ellen Abdulmassih
$1M
56
0.3 yrs
Rich Hoffman
Senior VP & Chief Accounting Officer
51
2 yrs
David Stahl
Executive VP & Chief Information Officer
53
1.1 yrs
Jennifer Koenig
Vice President of Corporate Communications & Investor Relations
Michael Weisman
Executive VP and Chief Ethics & Compliance Officer
59
1.1 yrs
S. White
Executive Vice President of Communication & Related Services
Joe Reuter
Executive VP & Chief People Officer
56
0.3 yrs
Board of Directors Tenure
Average tenure and age of the Stericycle board of directors in years:
- The tenure for the Stericycle board of directors is about average.
Board of Directors
Bob Murley
Chairman
$260K
68
1.2 yrs
Cindy Miller
President
$2M
55
0.3 yrs
Tom Brown
Director
$195K
70
11 yrs
Lynn Bleil
Director
$191K
55
4 yrs
Brian Anderson
Director
$200K
67
2.3 yrs
Mark Miller
Director
$165K
62
27 yrs
Mike Zafirovski
Director
$185K
64
6.5 yrs
Thomas Chen
Director
$185K
68
5 yrs
Kay Priestly
Director
$149K
62
0.9 yrs
Ronee Hagen
Director
$149K
72
0.9 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 14. Sep 18 | Sell | Brian Anderson | Individual | 30. May 17 | 13. Aug 18 | -320 | $81.76 | $-22,457 | ||
| 14. Sep 18 | Buy | Brian Anderson | Individual | 24. Jan 17 | 05. Jun 18 | 360 | $82.33 | $26,555 | ||
Management checks
We assess Stericycle's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Stericycle has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
SRCL News
Simply Wall St News
Is Stericycle, Inc.'s (NASDAQ:SRCL) Balance Sheet A Threat To Its Future?
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Stericycle, Inc. … However, history shows that overlooked mid-cap companies have performed better on a risk-adjusted manner than the smaller and larger segment of the market. … SRCL’s financial liquidity and debt position will be analysed in this article, to get an idea of whether the company can fund opportunities for strategic growth and maintain strength through economic downturns.
Simply Wall St - – Full articleWhat Does Stericycle, Inc.'s (NASDAQ:SRCL) Share Price Indicate?
(NASDAQ:SRCL), which is in the commercial services business, and is based in United States,. … As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock? … Let’s take a look at Stericycle’s outlook and value based on the most recent financial data to see if the opportunity still exists
Simply Wall St - – Full articleWhy Stericycle, Inc.’s (NASDAQ:SRCL) Return On Capital Employed Looks Uninspiring
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleDoes Stericycle, Inc.'s (NASDAQ:SRCL) Debt Level Pose A Problem?
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Stericycle, Inc. … While they are less talked about as an investment category, mid-cap risk-adjusted returns have generally been better than more commonly focused stocks that fall into the small- or large-cap categories. … This article will examine SRCL’s financial liquidity and debt levels to get an idea of whether the company can deal with cyclical downturns and maintain funds to accommodate strategic spending for future growth.
Simply Wall St - – Full articleIs Stericycle, Inc.'s (NASDAQ:SRCL) CEO Pay Justified?
This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Charles Alutto's Compensation Compare With Similar Sized Companies. … has a market cap of US$3.4b, and is paying total annual CEO compensation of US$3.8m.
Simply Wall St - – Full articleIs Stericycle, Inc.'s (NASDAQ:SRCL) ROE Of 5.6% Concerning?
This article is for those who would like to learn about Return On Equity (ROE). … Our data shows Stericycle has a return on equity of 5.6% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleWhat Should You Know About Stericycle Inc's (NASDAQ:SRCL) Capital Returns?
This share represents a portion of capital used by the company to operate the business, and it is important the company is able to use the capital base efficiently to create adequate cash flows for you as an investor. … This is because the actual cash flow generated by the business dictates the potential for income (dividends) and capital appreciation (price increases), which are the two ways to achieve positive returns when buying a stock. … Therefore, looking at how efficiently Stericycle is able to use capital to create earnings will help us understand your potential return.
Simply Wall St - – Full articleStericycle Inc (NASDAQ:SRCL): What We Can Expect From This Growth Stock
In June 2018, Stericycle Inc (NASDAQ:SRCL) released its earnings update. … analyst consensus outlook appear cautiously optimistic, … the past 5-year average growth rate of -29%
Simply Wall St - – Full articleIs Stericycle Inc (NASDAQ:SRCL) Excessively Paying Its CEO?
This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Charles Alutto's Compensation Compare With Similar Sized Companies. … When we examined a selection of companies with market caps ranging from US$2.0b to US$6.4b, we found the median CEO compensation was US$5m
Simply Wall St - – Full articleDoes Stericycle Inc's (NASDAQ:SRCL) Debt Level Pose A Problem?
Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as Stericycle Inc (NASDAQ:SRCL), with a market cap of US$5.28b, often get neglected by retail investors. … While they are less talked about as an investment category, mid-cap risk-adjusted returns have generally been better than more commonly focused stocks that fall into the small- or large-cap categories. … This article will examine SRCL’s financial liquidity and debt levels to get an idea of whether the company can deal with cyclical downturns and maintain funds to accommodate strategic spending for future growth.
Simply Wall St - – Full articleSRCL Company Info
Description
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, recall/return, and communication services. The company’s services also include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, and compliance services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products. In addition, it offers compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names; and live voice and automated communication services, including afterhours answering, appointment scheduling, appointment reminders, secure messaging, and event registration. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was founded in 1989 and is headquartered in Lake Forest, Illinois.
Details
| Name: | Stericycle, Inc. |
| SRCL | |
| Exchange: | NasdaqGS |
| Founded: | 1989 |
| $4,400,917,831 | |
| 91,040,915 | |
| Website: | http://www.stericycle.com |
| Address: |
Stericycle, Inc. 28161 North Keith Drive, Lake Forest, Illinois, 60045, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NasdaqGS | SRCL | Common Stock | Nasdaq Global Select | US | USD | 23. Aug 1996 | |
| DB | SY9 | Common Stock | Deutsche Boerse AG | DE | EUR | 23. Aug 1996 | |
| LSE | 0L9O | Common Stock | London Stock Exchange | GB | USD | 23. Aug 1996 |
Number of employees
Current staff
Industry
| Environmental and Facilities Services | |
| Commercial Services |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/05/20 01:42 |
| End of day share price update: | 2019/05/17 00:00 |
| Last estimates confirmation: | 2019/05/16 |
| Last earnings filing: | 2019/05/02 |
| Last earnings reported: | 2019/03/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
